The CA2 Gene Osteopetrosis Autosomal Recessive Type 3 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect mutations in the CA2 gene, which are responsible for causing Osteopetrosis Autosomal Recessive Type 3. Osteopetrosis is a rare bone disorder characterized by the abnormal density and structuring of bones, leading to various health complications. This genetic test plays a crucial role in the early diagnosis and management of the condition, enabling healthcare providers to tailor treatment plans effectively. The test is priced at 4400 AED and is conducted with precision and care by the experienced professionals at DNA Labs UAE, ensuring reliable results for patients and their families.
The CLCN7 Gene Osteopetrosis Autosomal Recessive Type 4 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the CLCN7 gene, which are responsible for Autosomal Recessive Osteopetrosis Type 4 (ARO4). Osteopetrosis is a rare bone disease characterized by the abnormal density and structuring of bones, leading to various health complications such as fractures, anemia, and impaired growth. The test is crucial for early diagnosis, enabling targeted treatment and management strategies for affected individuals.
This genetic test involves analyzing the patient's DNA to identify mutations in the CLCN7 gene, which plays a significant role in bone resorption and growth. By pinpointing specific genetic alterations, healthcare providers can confirm a diagnosis of ARO4, differentiate it from other types of osteopetrosis and related bone disorders, and guide families regarding the inheritance patterns and risks for future children.
The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify and interpret the genetic variations associated with this condition. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test adheres to stringent quality and accuracy standards, ensuring reliable results for patients and their families.
The OSTM1 Gene Osteopetrosis Autosomal Recessive Type 5 Genetic Test is a specialized diagnostic assessment designed to identify mutations in the OSTM1 gene, which are known to cause Osteopetrosis Autosomal Recessive Type 5. Osteopetrosis is a rare genetic disorder characterized by increased bone density and abnormal bone growth, which can lead to a variety of health issues, including fractures, anemia, and impaired vision. The condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to be affected by the disease.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. By analyzing a sample of the patient's DNA, the test can determine the presence of specific mutations in the OSTM1 gene that are responsible for the condition. This information is crucial for early diagnosis, which can significantly improve the management and treatment of the disease, potentially mitigating some of its more severe complications.
The cost of the OSTM1 Gene Osteopetrosis Autosomal Recessive Type 5 Genetic Test at DNA Labs UAE is 4400 AED. Although the price may seem high, the test provides invaluable information for affected individuals and their families, including insights into the likelihood of passing the condition on to future generations and enabling healthcare providers to tailor treatment plans more effectively.
The PLEKHM1 Gene Osteopetrosis Autosomal Recessive Type 6 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the PLEKHM1 gene which are responsible for Osteopetrosis Autosomal Recessive Type 6. This condition is a rare genetic disorder characterized by increased bone density and abnormal bone growth, which can lead to a variety of health issues including bone fragility, neurological complications, and impaired bone marrow function.
The test is designed to provide crucial information for the accurate diagnosis and management of the condition, enabling targeted treatment strategies and genetic counseling for affected families. By analyzing the patient's DNA, the test identifies specific mutations in the PLEKHM1 gene that are linked to the development of Osteopetrosis Autosomal Recessive Type 6, offering insights into the genetic basis of the disorder.
Priced at 4400 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of results. This genetic test is particularly important for individuals with a family history of the condition or those exhibiting symptoms related to abnormal bone growth and density, providing them with a definitive diagnosis and facilitating appropriate clinical interventions.
The TNFRSF11A gene plays a crucial role in the development and function of bones. Mutations in this gene can lead to a rare condition known as Osteopetrosis, specifically Autosomal Recessive Type 7. This condition is characterized by abnormally dense bones, which, paradoxically, can be more prone to fracture. The genetic test for this condition involves analyzing the TNFRSF11A gene to identify mutations that cause the disease. This testing is vital for early diagnosis and management of the condition, potentially guiding treatment options and genetic counseling.
DNA Labs UAE offers a comprehensive genetic test for the TNFRSF11A gene to diagnose Osteopetrosis Autosomal Recessive Type 7. The test is priced at 4400 AED. Conducting this test can provide essential information for affected individuals and their families, offering insights into the nature of the condition and informing decisions about care and management.
The LRP5 gene osteoporosis pseudoglioma syndrome genetic test is a specialized diagnostic tool used to detect mutations in the LRP5 gene, which are associated with osteoporosis pseudoglioma syndrome (OPPG). This rare genetic disorder is characterized by severe osteoporosis, leading to increased risk of fractures, and pseudoglioma, a condition resembling retinoblastoma but without the presence of an actual tumor. Symptoms typically manifest in early childhood, affecting bone density and vision.
The test involves analyzing the patient's DNA to identify specific mutations in the LRP5 gene that are known to cause OPPG. Early diagnosis through this genetic testing is crucial for managing symptoms, implementing appropriate treatments, and improving the quality of life for affected individuals.
Performed at DNA Labs UAE, the cost of the LRP5 gene osteoporosis pseudoglioma syndrome genetic test is 4400 AED. The facility ensures accurate and reliable results, utilizing advanced genomic technologies and adhering to high standards of laboratory practices. This test is a vital resource for families with a history of OPPG, providing essential information for genetic counseling and decision-making regarding family planning.
The KRT16 gene pachyonychia congenita type 1 genetic test is a specialized diagnostic tool used to identify mutations in the KRT16 gene, which are responsible for the development of Pachyonychia Congenita Type 1 (PC-1). Pachyonychia Congenita is a rare genetic skin disorder characterized by thickened nails, painful calluses and blisters on the soles of the feet, oral leukokeratosis, and sometimes cysts on the skin. The condition is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the KRT16 gene can cause the disorder.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, and analyzing the genetic material for specific mutations in the KRT16 gene. This genetic testing is crucial for the accurate diagnosis of PC-1, allowing for appropriate management and counseling for affected individuals and their families.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the cost of the KRT16 gene pachyonychia congenita type 1 genetic test is set at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced geneticists and technicians, ensuring reliable and accurate test results. This test not only aids in confirming the diagnosis of PC-1 but also plays a significant role in research aimed at understanding the disease better and developing potential treatments.
Pachyonychia Congenita Type 2 is a rare genetic disorder characterized by the thickening of the skin on the palms and soles, abnormal nail growth, and the development of cysts in various parts of the body. This condition is linked to mutations in the KRT17 gene, which provides instructions for making a protein that is crucial for the strength and resilience of skin, nails, and hair. Identifying mutations in the KRT17 gene can confirm a diagnosis of Pachyonychia Congenita Type 2, facilitating appropriate management and genetic counseling.
DNA Labs UAE offers a genetic test specifically designed to detect mutations in the KRT17 gene associated with Pachyonychia Congenita Type 2. This test is crucial for individuals exhibiting symptoms of the disorder or those with a family history of Pachyonychia Congenita, as it helps in confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding treatment plans.
The cost of the KRT17 Gene Pachyonychia Congenita Type 2 Genetic Test at DNA Labs UAE is 4400 AED. The test involves a simple procedure, typically requiring a blood sample or cheek swab from the patient. The sample is then analyzed in the laboratory for the presence of mutations in the KRT17 gene. Results from this test provide valuable insights into the genetic basis of the patient's condition, supporting more personalized and effective approaches to care.
Pachyonychia Congenita Type 3, associated with mutations in the KRT6A gene, is a rare genetic disorder characterized by thickened nails, painful palmoplantar keratoderma, and other skin abnormalities. The condition stems from mutations in the KRT6A gene, which plays a crucial role in the production of keratin, a protein essential for the strength and integrity of skin, nails, and hair.
To diagnose this specific subtype of Pachyonychia Congenita, genetic testing is performed to identify mutations in the KRT6A gene. DNA Labs UAE offers a specialized genetic test for Pachyonychia Congenita Type 3, aimed at individuals who exhibit symptoms of the disorder or have a family history of the condition. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect mutations in the KRT6A gene.
The cost of the KRT6A Gene Pachyonychia Congenita Type 3 Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is a crucial step in confirming the diagnosis, which can guide treatment options and help affected individuals and their families understand the implications of the disorder. Early diagnosis through genetic testing can also aid in the management of symptoms and improve the quality of life for those living with Pachyonychia Congenita Type 3.
The KRT6B Gene Pachyonychia Congenita Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the KRT6B gene, which are responsible for Pachyonychia Congenita Type 4. This rare genetic disorder is characterized by thickened nails, painful palmoplantar keratoderma, cysts, and other skin abnormalities. The test is crucial for accurate diagnosis, allowing for appropriate management and genetic counseling. At a cost of 4400 AED, this test offers individuals and families critical insights into the genetic basis of the condition, facilitating informed healthcare decisions.
